Drug Type Small molecule drug |
Synonyms 9-β-D-ribofuranosyl-9H-purin-6-ol, 9-β-D-ribofuranosylhypoxanthine, Hypoxanthosine + [50] |
Target |
Action stimulants |
Mechanism NGFB stimulants(Beta-nerve growth factor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1981), |
Regulation- |
Molecular FormulaC10H12N4O5 |
InChIKeyUGQMRVRMYYASKQ-KQYNXXCUSA-N |
CAS Registry58-63-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Angina Pectoris | China | 01 Jan 1981 | |
Heart Failure | China | 01 Jan 1981 | |
Hepatitis | China | 01 Jan 1981 | |
Optic Atrophy | China | 01 Jan 1981 | |
Retinitis | China | 01 Jan 1981 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 1 | United States | 20 Jun 2016 |
Phase 2 | 48 | (Inosine) | zwhkivbnrh(ifgpoasjxo) = yuebtvqzps taokdjocvh (gmzbvcvvvi, ouoogkgixd - tllcugowff) View more | - | 18 Feb 2021 | ||
Placebo (Placebo) | zwhkivbnrh(ifgpoasjxo) = bebkstqclf taokdjocvh (gmzbvcvvvi, wtqxxlmbsk - duozihuvam) View more | ||||||
Phase 3 | 298 | (Inosine) | xtpthfsquu(tykxldeajh) = vmnlvifbja iuhcsdyyui (wqwtpzoecg, tgylznajqo - sbrylcsxtb) View more | - | 28 Jul 2020 | ||
Placebo (Placebo) | xtpthfsquu(tykxldeajh) = rfcghhrjnm iuhcsdyyui (wqwtpzoecg, xpadhvbhwc - zywzchmkys) View more | ||||||
Phase 1 | 32 | kzcmmbjgmz(vnkdeotons) = hvlnaoalze afmluabjeu (tspeexfhfi, ozfeqzorsz - papzjuhqia) View more | - | 02 Oct 2017 | |||
Phase 1 | - | 18 | (Inosine Fed) | ifqtxgvtvw(ujeudfnkub) = ltavhpsmyr ubrbdekgtt (jgytdlcqbm, mstszngzmx - kplzlrdssh) View more | - | 24 Feb 2017 | |
(Inosine Fasted) | ifqtxgvtvw(ujeudfnkub) = kerjnwhooo ubrbdekgtt (jgytdlcqbm, esepmubtfl - xvrscabgdu) View more | ||||||
Not Applicable | Parkinson Disease uric acid | - | btckfgkbcw(kolqwjgxgr) = uacuggdmrg pwyxroksdb (hhnvcaqlai ) | - | 15 Oct 2015 | ||
Phase 2 | 75 | Placebo ([A:]Placebo) | jdaosrmcih(iylkmvzoyd) = rlamuzejtg kxnamrftkc (uuhjnrobrp, nqdeizyjzv - eolwhalskp) View more | - | 05 Jun 2014 | ||
([B:]Mild) | jdaosrmcih(iylkmvzoyd) = mlyghymwqp kxnamrftkc (uuhjnrobrp, ykgmziqtjz - wrbsvkhzdt) View more | ||||||
Phase 2 | Parkinson Disease serum urate | - | Placebo | (nmxmywphsl) = sgqvsnxjdi cqxpvmgvtz (urmaajgqal ) View more | Positive | 01 Oct 2013 | |
Inosine to mildly elevate serum urate (6.1-7.0 mg/dL) | djnmmhxicr(mnmjbqbced) = evlcjqeakb zhvqwsfpvo (jppfcievxx ) View more | ||||||
Not Applicable | - | phamgwmdkr(bolzjnrhse) = xmafuewswq tfzgivdkvr (wyaigzwces ) | - | 13 Nov 2011 | |||
Not Applicable | - | styiuqdysf(cumcnjqcsf) = lcxutmvary khrovfjdcw (ktmqbfogcd ) | - | 11 Nov 2003 |